Comparative Safety and Effectiveness of Biologic Therapy for Crohn’s Disease: A CA-IBD Cohort Study

By sjmartinez • July 25, 2023

Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S, Zheng K, Syal G, Ha C, Fleshner P, McGovern D, Sauk JS, Limketkai B, Dulai PS, Boland BS, Eisenstein S, Ramamoorthy S, Melmed G, Mahadevan U, Sandborn WJ, Ohno-Machado L. Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study. Clin Gastroenterol Hepatol. 2023 Aug;21(9):2359-2369.e5. doi: 10.1016/j.cgh.2022.10.029. Epub 2022 Nov 5. PMID: 36343846.

Tags: Biologics, Comparative Effectiveness, Digestive Diseases, Immunosuppressives, Inflammatory Bowel Diseases, Positioning, Publications

An Unusual Case of Chylous Ascites

Aung T, Celestin M, Bau S, Saab S. An Unusual Case of Chylous Ascites. Cureus. 2024 Dec 19;16(12):e76018. doi: 10.7759/cureus.76018. PMID: 39835005; PMCID: PMC11743697.

Sometimes Small Is Beautiful: Discovery of the Janus Kinases (JAK) and Signal Transducer and Activator of Transcription (STAT) Pathways and the Initial Development of JAK Inhibitors for IBD Treatment

Kaunitz JD. Sometimes Small Is Beautiful: Discovery of the Janus Kinases (JAK) and Signal Transducer and Activator of Transcription (STAT) Pathways and the Initial Development[...]

AGA Institute Quality Indicator Development for Irritable Bowel Syndrome

Hung KW, Leiman DA, Kaza A, Watson R, Chang L, Maratt JK; American Gastroenterological Association Quality Committee. Electronic address: dgodzina@gastro.org. AGA Institute Quality Indicator Development[...]